The phase 2 trial involved 560 healthy volunteers, and results show that the vaccine was able to prompt a response to COVID-19 within 14 days of the first dose. It produces a similar immune response among adults of all ages.
People over the age of 70 are at a high risk of developing severe illness if they contract COVID-19. The vaccine is now in phase 3 trials and is being tested to see if it can protect the elderly and people with underlying health conditions from COVID-19, The Hill reported.
Phase 3 trial results should be known by Christmas, AstraZeneca and the University of Oxford said.
Find the full study results here.
More articles on pharmacy:
3 key vaccine production challenges drugmakers are facing
What Amazon’s online pharmacy announcement did to CVS, Walgreens and Rite Aid stock
Every state will have COVID-19 vaccine within 24 hours of FDA’s OK, federal officials say
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
